These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 38511961)

  • 1.
    Francis VI; Liddle C; Camacho E; Kulkarni M; Junior SRS; Harvey JA; Ballou ER; Thomson DD; Brown GD; Hardwick JM; Casadevall A; Witton J; Coelho C
    mBio; 2024 Apr; 15(4):e0307823. PubMed ID: 38511961
    [No Abstract]   [Full Text] [Related]  

  • 2.
    Francis VI; Liddle C; Camacho E; Kulkarni M; Junior SRS; Harvey JA; Ballou ER; Thomson DD; Hardwick JM; Casadevall A; Witton J; Coelho C
    bioRxiv; 2023 Nov; ():. PubMed ID: 38014111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal Inoculation of Cryptococcus neoformans in Mice Produces Nasal Infection with Rapid Brain Dissemination.
    Coelho C; Camacho E; Salas A; Alanio A; Casadevall A
    mSphere; 2019 Aug; 4(4):. PubMed ID: 31391283
    [No Abstract]   [Full Text] [Related]  

  • 4. Invasion of the central nervous system by Cryptococcus neoformans requires a secreted fungal metalloprotease.
    Vu K; Tham R; Uhrig JP; Thompson GR; Na Pombejra S; Jamklang M; Bautos JM; Gelli A
    mBio; 2014 Jun; 5(3):e01101-14. PubMed ID: 24895304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucuronoxylomannan intranasal challenge prior to Cryptococcus neoformans pulmonary infection enhances cerebral cryptococcosis in rodents.
    Lee HH; Carmichael DJ; Ríbeiro V; Parisi DN; Munzen ME; Charles-Niño CL; Hamed MF; Kaur E; Mishra A; Patel J; Rooklin RB; Sher A; Carrillo-Sepulveda MA; Eugenin EA; Dores MR; Martinez LR
    PLoS Pathog; 2023 Apr; 19(4):e1010941. PubMed ID: 37115795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The primary target organ of Cryptococcus gattii is different from that of Cryptococcus neoformans in a murine model.
    Ngamskulrungroj P; Chang Y; Sionov E; Kwon-Chung KJ
    mBio; 2012; 3(3):. PubMed ID: 22570277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Live Imaging of Host-Parasite Interactions in a Zebrafish Infection Model Reveals Cryptococcal Determinants of Virulence and Central Nervous System Invasion.
    Tenor JL; Oehlers SH; Yang JL; Tobin DM; Perfect JR
    mBio; 2015 Sep; 6(5):e01425-15. PubMed ID: 26419880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methamphetamine enhances Cryptococcus neoformans pulmonary infection and dissemination to the brain.
    Patel D; Desai GM; Frases S; Cordero RJ; DeLeon-Rodriguez CM; Eugenin EA; Nosanchuk JD; Martinez LR
    mBio; 2013 Jul; 4(4):. PubMed ID: 23900172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative analysis reveals internalisation of Cryptococcus neoformans by brain endothelial cells in vivo.
    Chen Y; Li C; Sun D; Strickland AB; Liu G; Shi M
    Cell Microbiol; 2021 Jun; 23(6):e13330. PubMed ID: 33745221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. X-linked immunodeficient mice exhibit enhanced susceptibility to Cryptococcus neoformans Infection.
    Szymczak WA; Davis MJ; Lundy SK; Dufaud C; Olszewski M; Pirofski LA
    mBio; 2013 Jul; 4(4):. PubMed ID: 23820392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cryptococcus neoformans Chitin Synthase 3 Plays a Critical Role in Dampening Host Inflammatory Responses.
    Hole CR; Lam WC; Upadhya R; Lodge JK
    mBio; 2020 Feb; 11(1):. PubMed ID: 32071275
    [No Abstract]   [Full Text] [Related]  

  • 12. The Transcription Factor Pdr802 Regulates Titan Cell Formation and Pathogenicity of Cryptococcus neoformans.
    Reuwsaat JCV; Agustinho DP; Motta H; Chang AL; Brown H; Brent MR; Kmetzsch L; Doering TL
    mBio; 2021 Mar; 12(2):. PubMed ID: 33688010
    [No Abstract]   [Full Text] [Related]  

  • 13. Naïve B cells reduce fungal dissemination in Cryptococcus neoformans infected Rag1
    Dufaud C; Rivera J; Rohatgi S; Pirofski LA
    Virulence; 2018 Jan; 9(1):173-184. PubMed ID: 28837391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of Clinical Isolates to Establish Criteria for a Mouse Model of Latent
    Ding M; Smith KD; Wiesner DL; Nielsen JN; Jackson KM; Nielsen K
    Front Cell Infect Microbiol; 2021; 11():804059. PubMed ID: 35186781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methamphetamine Impairs IgG1-Mediated Phagocytosis and Killing of Cryptococcus neoformans by J774.16 Macrophage- and NR-9640 Microglia-Like Cells.
    Aslanyan L; Lee HH; Ekhar VV; Ramos RL; Martinez LR
    Infect Immun; 2019 Feb; 87(2):. PubMed ID: 30510106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T11TS immunotherapy augments microglial and lymphocyte protective immune responses against Cryptococcus neoformans in the brain.
    Hazra I; Sk Md OF; Datta A; Mondal S; Moitra S; Singh MK; Chaudhuri S; Das PK; Basu AK; Dhar I; Basu N; Chaudhuri S
    Scand J Immunol; 2019 Feb; 89(2):e12733. PubMed ID: 30450625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistence of infection in mice inoculated intranasally with Cryptococcus neoformans.
    Anderson DA; Sagha HM
    Mycopathologia; 1988 Dec; 104(3):163-9. PubMed ID: 3070384
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Woo YH; Martinez LR
    Crit Rev Microbiol; 2021 Mar; 47(2):206-223. PubMed ID: 33476528
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification of Pathogen Genomic Differences That Impact Human Immune Response and Disease during Cryptococcus neoformans Infection.
    Gerstein AC; Jackson KM; McDonald TR; Wang Y; Lueck BD; Bohjanen S; Smith KD; Akampurira A; Meya DB; Xue C; Boulware DR; Nielsen K
    mBio; 2019 Jul; 10(4):. PubMed ID: 31311883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucuronoxylomannan in the Cryptococcus species capsule as a target for Chimeric Antigen Receptor T-cell therapy.
    da Silva TA; Hauser PJ; Bandey I; Laskowski T; Wang Q; Najjar AM; Kumaresan PR
    Cytotherapy; 2021 Feb; 23(2):119-130. PubMed ID: 33303326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.